Blood Transfusion and Erythropoietin

Links shared publicly online about this topic

Erythropoietin

marvistavet.com — “ErythropoietinView full resource at marvistavet.com

  • View Related
  • Share

Most Recently Shared on November 8, 2009 at 12:28 am By:

NewportVet Newport Beach Vet Veterinarian

anemic Zabor, with chronic renal failure & developed antibodies to erythropoietin http://bit.ly/14Zg42 receives 5 units of packed-cell blood

3 years ago...

Erythropoietin - VeterinaryPartner.com - a VIN company!

veterinarypartner.com — “Erythropoietin - VeterinaryPartner.com - a VIN company!View full resource at veterinarypartner.com

  • View Related
  • Share

Most Recently Shared on April 16, 2010 at 6:50 pm By:

NewportVet Newport Beach Vet Veterinarian

began blood transfusion for Zabor; chronic renal failure, erythropoietin no longer an option http://bit.ly/aUJl6k

2 years ago...

Erythropoietin May Pose A Risk To Blood Vessels In The Brain And Body

medicalnewstoday.com — “Erythropoietin May Pose A Risk To Blood Vessels In The Brain And BodyView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 13, 2011 at 8:05 am By:

mnt_sportsmed MNT Sports Medicine Health News

Erythropoietin May Pose A Risk To Blood Vessels In The Brain And Body http://t.co/KUNzR4Xz #sportsmedicine

5 months ago...

Blood Transfusions

kidshealth.org — “A blood transfusion is a safe and relatively simple medical procedure that replaces blood lost during surgery or because of an injury or illness.View full resource at kidshealth.org

  • View Related
  • Share

Most Recently Shared on August 5, 2009 at 5:06 pm By:

Blood Transfusions

kidshealth.org — “More than 5 million people a year get blood transfusions in the United States. This article for teens explains why people need them and who donates the blood used.View full resource at kidshealth.org

  • View Related
  • Share

Most Recently Shared on January 28, 2011 at 7:30 pm By:

Erythropoietin Counteracts Breast Cancer Treatment with Herceptin

newswise.com — “Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on November 15, 2010 at 9:35 pm By:

newswise newswise Health Communicator and Health News

Erythropoietin Counteracts Breast Cancer Treatment with Herceptin: Red-blood-cell-boosting drugs used to treat a... http://bit.ly/c45KUW

2 years ago...

Erythropoietin counteracts breast cancer treatment with herceptin

physorg.com — “Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on November 15, 2010 at 9:50 pm By:

FightCancer FightCancer Health News

Erythropoietin counteracts breast cancer treatment with herceptin http://bit.ly/bsbAIO

2 years ago...

ArmaGen® Re-engineers Erythropoietin For Brain Penetration

medicalnewstoday.com — “Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development foView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 17, 2010 at 2:04 pm By:

mnt_pharma MNT Pharma News Health News and Pharma

ArmaGen® Re-engineers Erythropoietin For Brain Penetration http://mnt.to/3Gfn #pharma #pharmaceutical

2 years ago...

Study Examines Blood Biomarkers Upon Erythropoietin Treatment of Ischemic Stroke | Biomarker Commons

biomarkercommons.org — “Researchers at the Max Planck Institute of Experimental Medicine in Goettingen, Germany, led by Prof. Hannelore Ehrenreich, the University of Bremen and University of Hannover, in collaboration with Dr.View full resource at biomarkercommons.org

  • View Related
  • Share

Most Recently Shared on September 29, 2011 at 4:45 pm By:

Allergy/Immunology News & Articles - MDLinx - Erythropoietin on #MDlinx

mdlinx.com — “Allergy/Immunology News & Articles - MDLinx - Erythropoietin on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 14, 2010 at 6:05 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Erythropoietin Receptor Is Expressed on Human Peripheral Blood T and B Lymphocytes and Monocytes and Is... http://bit.ly/9xD0Qw #AI #mdlinx

2 years ago...

Administration of erythropoietin to patients with heart attack who undergo coronary intervention procedures

sciencedaily.com — “Intravenous administration of epoetin alfa, a product that stimulates red blood cell production, to patients with heart attack who were undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), did not provide reduction in the size of the heart muscle involved and was associated with higher rates of adverse cardiovascular events, according to a new study.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on May 10, 2011 at 10:53 pm By:

HeartsHealth Heart Health Health News

ScienceDaily: Administration of erythropoietin to patients with heart attack who undergo: http://bit.ly/irzqO7 Full http://bit.ly/lsfv7k

1 year ago...

Study examines outcomes of erythropoietin use for heart attack patients undergoing PCI

eurekalert.org — “Intravenous administration of epoetin alfa, a product that stimulates red blood cell production, to patients with heart attack who were undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), did not provide reduction in the size of the heart muscle involved and was associated with higher rates of adverse cardiovascular events, according to a study in the May 11 issue of JAMA.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on May 11, 2011 at 12:27 am By:

kidneynotes Kidney Notes Health News Feed

HDCN: Giving EPO to heart attack patients receiving PCI linked to increased infarct size. http://bit.ly/lu4BIU

1 year ago...

Hospira Begins Phase I U.S. Clinical Trial Of Biosimilar Erythropoietin In Renal Patients

medicalnewstoday.com — “Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 28, 2010 at 10:04 pm By:

medical_tweets medical_tweets Health News

Hospira Begins Phase I U.S. Clinical Trial Of Biosimilar Erythropoietin In Renal Patients Hospira, Inc. (NYSE: HSP), th.. http://dld.bz/pfYy

2 years ago...

Blood Transfusion-Overview

webmd.com — “What is a blood transfusion?Blood transfusion is a medical treatment to replace blood or portions of the blood lost through injury, surgery, or disease.When is a blood transfusion needed?A blood transfusion is needed if you have had significant blood loss or if your body cannot make or is losing an important component of blood.Blood may be lost through:Injury or major surgery.An illness that ...View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on July 24, 2010 at 9:43 pm By:

WebMD WebMD Health Site

Zsa Zsa Gabor remains critical after a blood transfusion. We wish her well. http://bit.ly/cJwsKU

2 years ago...

Medical News: No Reduction in Transfusions with ESAs - in Hematology/Oncology, Hematology from MedPage Today

medpagetoday.com — “Widespread use of erythropoiesis-stimulating agents among cancer patients undergoing chemotherapy has not resulted in the expected decrease in the rate of blood transfusions, a large retrospective cohView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on November 11, 2009 at 1:02 pm By:

medpagetoday MedPage Today Health News

Erythropoiesis-stimulating agents don't reduce the need for blood transfusions in cancer patients. More: http://bit.ly/2xp70o

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • NewportVet

    Newport Beach Vet

    Welcome to The Newport Beach Veterinary Hospital. General DVM & Internal Medicine Specialist Veterinarian helping dogs & cats of Orange County, California.

    View Profile

  • NewportVet

    Newport Beach Vet

    Welcome to The Newport Beach Veterinary Hospital. General DVM & Internal Medicine Specialist Veterinarian helping dogs & cats of Orange County, California.

    View Profile

  • mnt_sportsmed

    MNT Sports Medicine

    The latest sports medicine news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390